000			01960 a2200553 4500
005			20250517054728.0
264		0	_c20161005
008			201610s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2015.09.034 _2doi
040			_aNLM _beng _cNLM
100	1		_aSerizawa, Kenichi
245	0	0	_aEpoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats. _h[electronic resource]
260			_bEuropean journal of pharmacology _cNov 2015
300			_a10-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aCreatinine _xblood
650	0	4	_aDisease Models, Animal
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aErythropoietin _xpharmacology
650	0	4	_aFemoral Artery _xdiagnostic imaging
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHemoglobins _xmetabolism
650	0	4	_aKidney Function Tests
650	0	4	_aMale
650	0	4	_aNADPH Oxidase 4
650	0	4	_aNADPH Oxidases _xbiosynthesis
650	0	4	_aNephrectomy
650	0	4	_aNitric Oxide Synthase Type III _xmetabolism
650	0	4	_aNitroglycerin _xpharmacology
650	0	4	_aPolyethylene Glycols _xpharmacology
650	0	4	_aProteinuria _xurine
650	0	4	_aRats
650	0	4	_aRenal Insufficiency, Chronic _xblood
650	0	4	_aTyrosine _xanalogs & derivatives
650	0	4	_aUltrasonography
650	0	4	_aVasodilation _xdrug effects
700	1		_aYogo, Kenji
700	1		_aTashiro, Yoshihito
700	1		_aAizawa, Ken
700	1		_aKawasaki, Ryohei
700	1		_aHirata, Michinori
700	1		_aEndo, Koichi
773	0		_tEuropean journal of pharmacology _gvol. 767 _gp. 10-6
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2015.09.034 _zAvailable from publisher's website
999			_c25320978 _d25320978